Literature DB >> 7824672

Preliminary evidence for an association between minor physical anomalies and second trimester neurodevelopment in schizophrenia.

M F Green1, H S Bracha, P Satz, C D Christenson.   

Abstract

Two types of markers, dermatoglyphics and minor physical anomalies, have been used as indicators of problems with fetal neurodevelopment in schizophrenia. The degree to which these markers overlap is not known. While it is agreed that abnormal dermatoglyphics reflect early second trimester maldevelopment, the timing of the development of minor physical anomalies has not been determined. Forty-six schizophrenic patients received assessments for minor physical anomalies, dermatoglyphics (right-left ridge count asymmetry and total finger ridge count), and information processing. Higher scores for minor physical anomalies were associated with greater dermatoglyphic asymmetry. Patients who had both types of indicators (high minor physical anomalies and dermatoglyphic asymmetry) did not differ on information-processing measures from patients who had neither. On the basis of the timing of dermatoglyphic development (weeks 14-22 of gestation), the association between minor physical anomalies and dermatoglyphic asymmetry suggests that the relatively high rate of minor physical anomalies observed in schizophrenia can be considered to reflect at least second trimester maldevelopment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7824672     DOI: 10.1016/0165-1781(94)90103-1

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  16 in total

1.  Patterns of dysmorphic features in schizophrenia.

Authors:  L E Scutt; E W Chow; R Weksberg; W G Honer; A S Bassett
Journal:  Am J Med Genet       Date:  2001-12-08

2.  Perinatal factors, parenting behavior, and reactive aggression: does cortisol reactivity mediate this developmental risk process?

Authors:  Stacy R Ryan; Julia C Schechter; Patricia A Brennan
Journal:  J Abnorm Child Psychol       Date:  2012-11

3.  Neonatal phencyclidine administration and post-weaning social isolation as a dual-hit model of 'schizophrenia-like' behaviour in the rat.

Authors:  Philip L R Gaskin; Stephen P H Alexander; Kevin C F Fone
Journal:  Psychopharmacology (Berl)       Date:  2014-01-09       Impact factor: 4.530

4.  Negative modulation of GABAA α5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats.

Authors:  John P Redrobe; Lisbeth Elster; Kristen Frederiksen; Christoffer Bundgaard; Inge E M de Jong; Garrick P Smith; Anne Techau Bruun; Peter H Larsen; Michael Didriksen
Journal:  Psychopharmacology (Berl)       Date:  2011-11-29       Impact factor: 4.530

5.  Minor physical anomalies in familial and sporadic schizophrenia: the Maudsley family study.

Authors:  T D Griffiths; T Sigmundsson; N Takei; S Frangou; P B Birkett; T Sharma; A M Reveley; R M Murray
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

Review 6.  Prevention of schizophrenia: can it be achieved?

Authors:  Cheng Lee; Thomas H McGlashan; Scott W Woods
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

7.  Minor physical anomalies in schizophrenia: a meta-analysis.

Authors:  Seth M Weinberg; Elizabeth A Jenkins; Mary L Marazita; Brion S Maher
Journal:  Schizophr Res       Date:  2006-10-31       Impact factor: 4.939

8.  In vitro and in vivo characterisation of Lu AF64280, a novel, brain penetrant phosphodiesterase (PDE) 2A inhibitor: potential relevance to cognitive deficits in schizophrenia.

Authors:  John P Redrobe; Morten Jørgensen; Claus T Christoffersen; Liliana P Montezinho; Jesper F Bastlund; Martin Carnerup; Christoffer Bundgaard; Linda Lerdrup; Niels Plath
Journal:  Psychopharmacology (Berl)       Date:  2014-03-01       Impact factor: 4.530

9.  Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia--sub-chronic and early postnatal PCP treatment in attentional set-shifting.

Authors:  Brian Villumsen Broberg; Birte Yding Glenthøj; Rebecca Dias; Dorrit Bjerg Larsen; Christina Kurre Olsen
Journal:  Psychopharmacology (Berl)       Date:  2009-04-24       Impact factor: 4.530

Review 10.  The presentation of dermatoglyphic abnormalities in schizophrenia: a meta-analytic review.

Authors:  Shana Golembo-Smith; Deborah J Walder; Maureen P Daly; Vijay A Mittal; Emily Kline; Gloria Reeves; Jason Schiffman
Journal:  Schizophr Res       Date:  2012-10-29       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.